Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial

Abstract Background Acute gouty arthritis (AGA) is an inflammatory arthritis clinically characterized by severe pain, swelling, and restricted movement of joints, which may cause physical disability and decrease quality of life. The use of recommended first-line treatment agents for AGA may be limit...

Full description

Bibliographic Details
Main Authors: Ya-xi Shang, Xia Dong, Zhi-min Xie, Xiao-peng Li, Xin-chang Wang, Ji-yong Huang, Shu-feng Wei, Yuan Liu, Jian-ping Liu
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-022-06338-1
_version_ 1818201865277407232
author Ya-xi Shang
Xia Dong
Zhi-min Xie
Xiao-peng Li
Xin-chang Wang
Ji-yong Huang
Shu-feng Wei
Yuan Liu
Jian-ping Liu
author_facet Ya-xi Shang
Xia Dong
Zhi-min Xie
Xiao-peng Li
Xin-chang Wang
Ji-yong Huang
Shu-feng Wei
Yuan Liu
Jian-ping Liu
author_sort Ya-xi Shang
collection DOAJ
description Abstract Background Acute gouty arthritis (AGA) is an inflammatory arthritis clinically characterized by severe pain, swelling, and restricted movement of joints, which may cause physical disability and decrease quality of life. The use of recommended first-line treatment agents for AGA may be limited by adverse events. There has been a traditional use of alternative therapies for AGA. Tibetan medicine Qingpeng ointment is one of the on-market herbal products used for symptom relief of AGA. Previous clinical studies indicated that Qingpeng ointment can relieve pain, swelling, redness, and dysfunction of joints in patients with AGA. However, there is no rigorous randomized trial to demonstrate its benefit for AGA. In order to evaluate the efficacy and safety of Qingpeng ointment for AGA, we designed a randomized controlled trial. Methods This study is designed as a multi-center, randomized, double-blind, placebo-controlled trial. Two hundred and six adults with acute flare of gout, and visual analogue scale (VAS) score of joint pain ≥ 3 points will be recruited. Participants will be randomly assigned to herbal treatment or placebo group at a ratio of 1:1. Qingpeng ointment, or equal placebo ointment, will be applied topically at involved joints twice a day for consecutive 7 days. Patients in both groups would be allowed giving diclofenac sodium sustained-release tablets as rescue therapy when VAS score of joint pain ≥ 7 points during the treatment. The primary outcomes will be joint pain measured by VAS score, and joint swelling measured using width and thickness of affected joints and VAS score. Other outcome measures will be joint mobility, joint redness, C-reactive protein, serum uric acid, and the use of rescue medicine as well as adverse effect. Discussion To the best of our knowledge, this study is the first multi-center, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy of Tibetan medicine Qingpeng ointment for AGA. The findings of this study would provide evidence for its use to relieve symptoms of AGA. Trial registration ISRCTN ISRCTN34355813 . Registered on 25 January 2021
first_indexed 2024-12-12T03:00:20Z
format Article
id doaj.art-9ca9b137bdea4319a50e4080f557a8e0
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-12-12T03:00:20Z
publishDate 2022-05-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-9ca9b137bdea4319a50e4080f557a8e02022-12-22T00:40:38ZengBMCTrials1745-62152022-05-0123111010.1186/s13063-022-06338-1Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trialYa-xi Shang0Xia Dong1Zhi-min Xie2Xiao-peng Li3Xin-chang Wang4Ji-yong Huang5Shu-feng Wei6Yuan Liu7Jian-ping Liu8Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese MedicineFangshan Hospital, Beijing University of Chinese MedicineThe Second Affiliated Hospital of Zhejiang Chinese Medical UniversityThe Second Affiliated Hospital of Zhejiang Chinese Medical UniversityThe Second Affiliated Hospital of Zhejiang Chinese Medical UniversityThe Second Affiliated Hospital of Zhejiang Chinese Medical UniversityFangshan Hospital, Beijing University of Chinese MedicineLiuzhou People’s HospitalCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese MedicineAbstract Background Acute gouty arthritis (AGA) is an inflammatory arthritis clinically characterized by severe pain, swelling, and restricted movement of joints, which may cause physical disability and decrease quality of life. The use of recommended first-line treatment agents for AGA may be limited by adverse events. There has been a traditional use of alternative therapies for AGA. Tibetan medicine Qingpeng ointment is one of the on-market herbal products used for symptom relief of AGA. Previous clinical studies indicated that Qingpeng ointment can relieve pain, swelling, redness, and dysfunction of joints in patients with AGA. However, there is no rigorous randomized trial to demonstrate its benefit for AGA. In order to evaluate the efficacy and safety of Qingpeng ointment for AGA, we designed a randomized controlled trial. Methods This study is designed as a multi-center, randomized, double-blind, placebo-controlled trial. Two hundred and six adults with acute flare of gout, and visual analogue scale (VAS) score of joint pain ≥ 3 points will be recruited. Participants will be randomly assigned to herbal treatment or placebo group at a ratio of 1:1. Qingpeng ointment, or equal placebo ointment, will be applied topically at involved joints twice a day for consecutive 7 days. Patients in both groups would be allowed giving diclofenac sodium sustained-release tablets as rescue therapy when VAS score of joint pain ≥ 7 points during the treatment. The primary outcomes will be joint pain measured by VAS score, and joint swelling measured using width and thickness of affected joints and VAS score. Other outcome measures will be joint mobility, joint redness, C-reactive protein, serum uric acid, and the use of rescue medicine as well as adverse effect. Discussion To the best of our knowledge, this study is the first multi-center, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy of Tibetan medicine Qingpeng ointment for AGA. The findings of this study would provide evidence for its use to relieve symptoms of AGA. Trial registration ISRCTN ISRCTN34355813 . Registered on 25 January 2021https://doi.org/10.1186/s13063-022-06338-1GoutAcute gouty arthritisJoint painQingpeng ointmentTibetan medicineRandomized controlled trial
spellingShingle Ya-xi Shang
Xia Dong
Zhi-min Xie
Xiao-peng Li
Xin-chang Wang
Ji-yong Huang
Shu-feng Wei
Yuan Liu
Jian-ping Liu
Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
Trials
Gout
Acute gouty arthritis
Joint pain
Qingpeng ointment
Tibetan medicine
Randomized controlled trial
title Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
title_full Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
title_fullStr Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
title_full_unstemmed Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
title_short Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
title_sort efficacy and safety of tibetan medicine qingpeng ointment for acute gouty arthritis protocol for a multi center randomized double blind placebo controlled trial
topic Gout
Acute gouty arthritis
Joint pain
Qingpeng ointment
Tibetan medicine
Randomized controlled trial
url https://doi.org/10.1186/s13063-022-06338-1
work_keys_str_mv AT yaxishang efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial
AT xiadong efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial
AT zhiminxie efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial
AT xiaopengli efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial
AT xinchangwang efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial
AT jiyonghuang efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial
AT shufengwei efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial
AT yuanliu efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial
AT jianpingliu efficacyandsafetyoftibetanmedicineqingpengointmentforacutegoutyarthritisprotocolforamulticenterrandomizeddoubleblindplacebocontrolledtrial